← Open Payments lookup

LINDA HUNTER: Open Payments

NPI 1376555045 · RICHLAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$524 in 14 payments from 9 companies in 2025. Trend: 2023 $610 · 2024 $610 · 2025 $524

Food & beverage: $524
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$128
Kowa Pharmaceuticals America, Inc.1$105
Novo Nordisk Inc2$85
ABBVIE INC.3$73
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$38
AstraZeneca Pharmaceuticals LP2$35
Amgen Inc.1$23
Phathom Pharmaceuticals, Inc.1$22
Boehringer Ingelheim Pharmaceuticals, Inc.1$14

Products named: CAPLYTA, ZORYVE, Ozempic, XIFAXAN, AIRSUPRA, SYNTHROID, UBRELVY, OTEZLA.

Industry payments across MS — which companies pay providers there.